Perampanel: first-in-class AED for partial-onset seizures

    loading  Checking for direct PDF access through Ovid

Abstract

Perampanel (Fycompa), an AMPA receptor antagonist, is licensed as adjunctive treatment of partial-onset seizures. In our New products review, Steve Chaplin presents the clinical data relating to its efficacy and adverse events and Dr Andrew Kelso discusses its place in the treatment of epilepsy.

Related Topics

    loading  Loading Related Articles